Last updated: May 8, 2024
Sponsor: Lorenzo delSorbo
Overall Status: Active - Recruiting
Phase
N/A
Condition
Respiratory Failure
Lung Injury
Acute Respiratory Distress Syndrome (Ards)
Treatment
Acute hypoxemic respiratory failure patients on VV-ECMO
Clinical Study ID
NCT05196074
21-5784
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Acute hypoxemic respiratory failure
- VV-ECMO
- Less than 24 hours from ECMO cannulation
Exclusion
Exclusion Criteria:
- Air leak
- VV-ECMO as bridge to lung transplantation
- Status asthmaticus
Study Design
Total Participants: 299
Treatment Group(s): 1
Primary Treatment: Acute hypoxemic respiratory failure patients on VV-ECMO
Phase:
Study Start date:
April 04, 2022
Estimated Completion Date:
April 30, 2026
Connect with a study center
Toronto General Hospital
Toronto, Ontario M5G 2N2
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.